A retrospective study in the journal Liver International found use of direct-acting antivirals may be associated with the reduced number of patients on a waiting list for a liver transplant for decompensated hepatitis C virus cirrhosis. Researchers found an increase in HCV patients whose indication for liver transplant was hepatocellular carcinoma during the study period, however. Steatohepatitis is surpassing HCV as the leading cause of indication for liver transplant, in part due to the highly effective treatments for HCV now available.

See a review article on Medscape here.